CLOSE ASSET MANAGEMENT LTD – Neurocrine Biosciences, Inc. Transaction History
CLOSE ASSET MANAGEMENT LTD portfolio value:
$28,000
portfolio value
CLOSE ASSET MANAGEMENT LTD quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2K | $106.21 | 268 | |
| Q2 2022 | share | 0.00% | 0 shares | 3K | $97.48 | 268 | |
| Q1 2022 | share | 0.00% | 0 shares | 0 | $93.75 | 268 | |
| Q4 2021 | share | 0.00% | 0 shares | -3K | $84.63 | 268 | |
| Q3 2021 | share | 0.00% | 0 shares | 0 | $95.91 | 268 | |
| Q2 2021 | share | 0.00% | 0 shares | 0 | $97.32 | 268 | |
| Q1 2021 | share | 0.00% | 0 shares | 0 | $97.25 | 268 | |
| Q4 2020 | share | 0.00% | 0 shares | 0 | $95.85 | 268 | |
| Q3 2020 | share | 0.00% | 0 shares | -7K | $96.16 | 268 | |
| Q2 2020 | share | 0.00% | 0 shares | 10K | $122 | 268 | |
| Q1 2020 | share | 0.00% | 0 shares | -6K | $86.55 | 268 | |
| Q4 2019 | share | 0.00% | 0 shares | 5K | $107.49 | 268 | |
| Q3 2019 | share | 0.00% | 0 shares | 1K | $90.11 | 268 | |
| Q2 2019 | share | 0.00% | 0 shares | -1K | $84.43 | 268 | |
| Q1 2019 | share | Decrease | -99.97% | -1.03M shares | -105.65M | $88.1 | 268 |
| Q4 2018 | share | Increase | +387751.49% | 1.03M shares | 105.64M | $71.41 | 1.03M |
| Q3 2018 | share | Decrease | -27.17% | -100 shares | 4K | $122.95 | 268 |
| Q2 2018 | share | 0.00% | 0 shares | 0 | $98.24 | 368 | |
| Q1 2018 | share | 0.00% | 0 shares | 0 | $82.93 | 368 | |
| Q4 2017 | share | 0.00% | 0 shares | 6K | $77.59 | 368 | |
| Q3 2017 | share | 0.00% | 0 shares | 6K | $61.28 | 368 | |
| Q2 2017 | share | 0.00% | 0 shares | 1K | $46 | 368 | |
| Q1 2017 | share | 0.00% | 0 shares | 2K | $43.3 | 368 | |
| Q4 2016 | share | Increase | 0.00% | 368 shares | 14K | $38.7 | 368 |